您当前的位置：
首页 >
文章列表页 >
Mechanism of Astragaloside Ⅳ in Regulating PI3K/Akt Molecular Pathway in Prevention and Treatment of Diabetes Complications： A Review
更新时间：2025-04-02

    • Mechanism of Astragaloside Ⅳ in Regulating PI3K/Akt Molecular Pathway in Prevention and Treatment of Diabetes Complications： A Review

    • “According to the latest research report, astragaloside A can reduce pancreatic cytotoxicity, protect heart function, improve neurological disorders, reduce kidney and liver damage, and provide new ideas for the treatment of diabetes and its complications by regulating PI3K/Akt pathway.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 9, Pages: 307-314(2025)

    • DOI：10.13422/j.cnki.syfjx.20250998    

      CLC： R259;R587.2;R781.6+4

    • Received：26 September 2024，

      Accepted：17 February 2025，

      Published Online：20 February 2025，

      Published：05 May 2025

    移动端阅览

  • HU Kexin,ZHU Jinru,WU Qing,et al.Mechanism of Astragaloside Ⅳ in Regulating PI3K/Akt Molecular Pathway in Prevention and Treatment of Diabetes Complications： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(09):307-314. DOI： 10.13422/j.cnki.syfjx.20250998.

  •  
  •  

0

Views

75

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis of Mechanism of Astragaloside Ⅳ in Regulating Ferroptosis Through SLC7A11/GPX4 Pathway Against Vascular Smooth Muscle Cell Proliferation
Molecular Mechanism of Action of Astragaloside Ⅳ in Modulating Pyroptosis to Attenuate Intestinal Ischemia-reperfusion Injury Based on Experimental Validation
Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway
Astragaloside Ⅳ Induces Autophagy and Apoptosis in Nasopharyngeal Carcinoma Cells via PI3K/Akt/mTOR Pathway

Related Author

FANG Zhaohui
LI Guoting
YANG Changchao
LIU Lin
LI Weikang
ZHAO Zixian
SHEN Quan
ZHAO Jingshan

Related Institution

Key Laboratory of Xin'an Medical Education Department （Anhui University of Chinese Medicine）
Hebei Key Laboratory of Traditional Chinese Medicine（TCM） Research on Cardiocerebrovascular Disease，TCM Processing Technology Innovation Center of Hebei Province，College of Pharmacy， Hebei University of Chinese Medicine
The First Hospital of Lanzhou University
The First Clinical Medical College of Lanzhou University
Hunan University of traditional Chinese medicine
0